Challenges in precision medicine in pancreatic cancer: A focus in cancer stem cells and microbiota

Pancreatic cancer adenocarcinoma (PDAC) is a lethal disease, with the lowest 5-years survival rate of all cancers due to late diagnosis. Despite the advance and success of precision oncology in gastrointestinal cancers, the frequency of molecular-informed therapy decisions in PDAC is currently negle...

Descripción completa

Detalles Bibliográficos
Autores principales: Perelló-Reus, Catalina M., Rubio-Tomás, Teresa, Cisneros-Barroso, Eugenia, Ibargüen-González, Lesly, Segura-Sampedro, Juan José, Morales-Soriano, Rafael, Barceló, Carles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751445/
https://www.ncbi.nlm.nih.gov/pubmed/36531066
http://dx.doi.org/10.3389/fonc.2022.995357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751445/
https://www.ncbi.nlm.nih.gov/pubmed/36531066
http://dx.doi.org/10.3389/fonc.2022.995357

Ejemplares similares